These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7124770

  • 1. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
    Neidhart JA, Roach RW.
    Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
    [Abstract] [Full Text] [Related]

  • 2. Therapy of the Kasabach-Merritt syndrome with cryoprecipitate plus intra-arterial thrombin and aminocaproic acid.
    Stahl RL, Henderson JM, Hooks MA, Martin LG, Duncan A.
    Am J Hematol; 1991 Apr; 36(4):272-4. PubMed ID: 1901445
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of Kasabach-Merritt syndrome with prednisone and epsilon-aminocaproic acid.
    Dresse MF, David M, Hume H, Blanchard H, Russo P, Van Doesberg N, Rivard GE.
    Pediatr Hematol Oncol; 1991 Apr; 8(4):329-34. PubMed ID: 1669958
    [Abstract] [Full Text] [Related]

  • 4. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
    Schwartz BS, Williams EC, Conlan MG, Mosher DF.
    Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
    [Abstract] [Full Text] [Related]

  • 5. Antifibrinolytic therapy in the management of the Kasabach Merritt syndrome.
    Ortel TL, Onorato JJ, Bedrosian CL, Kaufman RE.
    Am J Hematol; 1988 Sep; 29(1):44-8. PubMed ID: 3177369
    [Abstract] [Full Text] [Related]

  • 6. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
    Kang Y, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE.
    Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
    [Abstract] [Full Text] [Related]

  • 7. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS].
    VAIREL E, LANDE M, LEGER L.
    Presse Med (1893); 1964 Mar 28; 72():945-6. PubMed ID: 14119753
    [No Abstract] [Full Text] [Related]

  • 8. The influence of epsilon-aminocaproic acid on the mineralocorticoid hypertension of the rat.
    Hartig F, Sponer G, Bartsch W, von Möllendorf E.
    Exp Pathol; 1981 Mar 28; 19(4):199-205. PubMed ID: 7250299
    [Abstract] [Full Text] [Related]

  • 9. Thromboelastographic evidence of inhibition of fibrinolysis after ε-aminocaproic acid administration in a dog with suspected acute traumatic coagulopathy.
    Yoo SH, Venn E, Sullivan LA, Olver CS.
    J Vet Emerg Crit Care (San Antonio); 2016 Sep 28; 26(5):737-42. PubMed ID: 26990227
    [Abstract] [Full Text] [Related]

  • 10. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M, YVER J, SAMAMA M, DUBOST C.
    Presse Med (1893); 1963 Sep 28; 71():1879-80. PubMed ID: 14091607
    [No Abstract] [Full Text] [Related]

  • 11. Pathological fibrinolytic states and their treatment with epsilon aminocaproic acid (EACA).
    McNicol GP, Browne MK, Bayley C, Douglas AS.
    Br J Surg; 1966 Jan 28; 53(1):26-9. PubMed ID: 5901909
    [No Abstract] [Full Text] [Related]

  • 12. Epsilon-aminocaproic acid (EACA).
    Griffin JD, Ellman L.
    Semin Thromb Hemost; 1978 Jan 28; 5(1):27-40. PubMed ID: 568312
    [Abstract] [Full Text] [Related]

  • 13. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACID].
    MARCHAL G, BILSKI-PASQUIER G, SAMAMA M.
    Hemostase; 1964 Mar 28; 4():95-101. PubMed ID: 14188681
    [No Abstract] [Full Text] [Related]

  • 14. USE OF EPSILON AMINOCAPROIC ACID.
    GANS H.
    Surg Gynecol Obstet; 1965 Mar 28; 120():576-7. PubMed ID: 14262059
    [No Abstract] [Full Text] [Related]

  • 15. Epsilon-aminocaproic acid in the reversal of consumptive coagulopathy with platelet sequestration in a vascular malformation of Klippel-Trenaunay syndrome.
    Poon MC, Kloiber R, Birdsell DC.
    Am J Med; 1989 Aug 28; 87(2):211-3. PubMed ID: 2547315
    [No Abstract] [Full Text] [Related]

  • 16. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS.
    BRODSKY I, ROSS E, REID WO.
    Am J Clin Pathol; 1964 Jun 28; 41():589-96. PubMed ID: 14183048
    [No Abstract] [Full Text] [Related]

  • 17. Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid.
    Chang JC, Kane KK.
    Am J Clin Pathol; 1984 Mar 28; 81(3):382-7. PubMed ID: 6702732
    [Abstract] [Full Text] [Related]

  • 18. Epsilon aminocaproic acid in hemophiliacs undergoing dental extractions: a concise review.
    Lucas ON, Albert TW.
    Oral Surg Oral Med Oral Pathol; 1981 Feb 28; 51(2):115-20. PubMed ID: 6782532
    [Abstract] [Full Text] [Related]

  • 19. Epsilon aminocaproic acid.
    Br Med J; 1967 Dec 23; 4(5581):725-6. PubMed ID: 6070179
    [No Abstract] [Full Text] [Related]

  • 20. Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid.
    Cooper DL, Sandler AB, Wilson LD, Duffy TP.
    Cancer; 1992 Aug 01; 70(3):656-8. PubMed ID: 1623480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.